Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 3,449–3,456 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Rafael Holdings Inc. Class B CPI-613 (devimistat) + cytarabine + mitoxantrone - (ARMADA 2000) Acute myeloid leukemia (AML) Phase 3 Trial Discontinued Intravenous Oncology
Rafael Holdings Inc. Class B CPI-613 (devimistat) + mFOLFIRINOX - (AVENGER 500) Pancreatic Cancer Phase 3 Trial Completed Intravenous Oncology
Rafael Holdings Inc. Class B Trappsol Cyclo Alzheimer’s Disease Phase 2b Ongoing Intravenous Neurology
Rafael Holdings Inc. Class B AMT-101 - (CASTRO) Rheumatoid arthritis Phase 2 Ongoing oral Immunology: Anti-TNF
Rafael Holdings Inc. Class B AMT-101 combo with with anti-TNFα - (MARKET) Ulcerative colitis Phase 2 Trial Completed Oral Gastroenterology
Rafael Holdings Inc. Class B AMT-101 - (FILLMORE) Pouchitis Phase 2 Ongoing Oral Gastroenterology
Rafael Holdings Inc. Class B AMT-101 monotherapy - (LOMBARD) Ulcerative colitis Phase 2 Trial Planned oral Gastroenterology
Rafael Holdings Inc. Class B CPI-613 (devimistat) + bendamustine Relapsed or Refractory T - cell Lymphoma Phase 2 Trial Completed Intravenous Oncology
1…430431432433434…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.